Effect of early intravenous heparin on coronary patency infarct size, and bleeding complications after alteplase thrombolysis.
Massel
D R
DR
D006470:Hemorrhage / Q000209:etiology; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000473:pathology; D015912:Thrombolytic Therapy / Q000379:methods*; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D014654:Vascular Patency
D006493:Heparin; D010959:Tissue Plasminogen Activator